AN ACT AUTHORIZING THE STATE TO MANUFACTURE CERTAIN GENERIC DRUGS.

This bill authorizes the state to manufacture specific generic drugs, directly affecting state government operations and potentially impacting healthcare costs. The key provision amends existing statutes to grant the state legal permission to produce these medications rather than purchasing them from private manufacturers. By enabling in-house production, the bill aims to provide the state with greater control over drug procurement for state agencies and employees. The legislation does not specify which drugs would be included or outline detailed operational procedures for the manufacturing process.